- Home
- TSBX vs DOMH Comparison
TSBX vs DOMH Comparison
Compare TSBX & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- DOMH
- Stock Information
- Founded
- TSBX 2015
- DOMH 1967
- Country
- TSBX United States
- DOMH United States
- Employees
- TSBX N/A
- DOMH N/A
- Industry
- TSBX
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- TSBX
- DOMH Health Care
- Exchange
- TSBX Nasdaq
- DOMH Nasdaq
- Market Cap
- TSBX 10.2M
- DOMH 8.8M
- IPO Year
- TSBX 2023
- DOMH N/A
- Fundamental
- Price
- TSBX $0.43
- DOMH $1.35
- Analyst Decision
- TSBX Buy
- DOMH
- Analyst Count
- TSBX 3
- DOMH 0
- Target Price
- TSBX $4.75
- DOMH N/A
- AVG Volume (30 Days)
- TSBX 158.9K
- DOMH 70.1K
- Earning Date
- TSBX 03-20-2025
- DOMH 11-08-2024
- Dividend Yield
- TSBX N/A
- DOMH N/A
- EPS Growth
- TSBX N/A
- DOMH N/A
- EPS
- TSBX N/A
- DOMH N/A
- Revenue
- TSBX N/A
- DOMH $12,589,000.00
- Revenue This Year
- TSBX N/A
- DOMH N/A
- Revenue Next Year
- TSBX N/A
- DOMH N/A
- P/E Ratio
- TSBX N/A
- DOMH N/A
- Revenue Growth
- TSBX N/A
- DOMH 1117.50
- 52 Week Low
- TSBX $0.40
- DOMH $0.83
- 52 Week High
- TSBX $5.75
- DOMH $3.20
- Technical
- Relative Strength Index (RSI)
- TSBX 39.13
- DOMH 55.06
- Support Level
- TSBX $0.41
- DOMH $1.00
- Resistance Level
- TSBX $0.62
- DOMH $1.29
- Average True Range (ATR)
- TSBX 0.06
- DOMH 0.12
- MACD
- TSBX -0.01
- DOMH 0.05
- Stochastic Oscillator
- TSBX 8.96
- DOMH 84.21
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.